JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB264870

Human TNK1 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

TNK1 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 2 and Insertion of the selection cassette in exon 2. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.

View Alternative Names

CD38 negative kinase 1, EC 2.7.10.2, Kinase of embryonic stem cells, Kos 1, MGC46193, Non-receptor tyrosine-protein kinase TNK1, TNK1_HUMAN, Tyrosine kinase non receptor 1

2 Images
Sanger Sequencing - Human TNK1 knockout HeLa cell line (AB264870)
  • Sanger seq

Unknown

Sanger Sequencing - Human TNK1 knockout HeLa cell line (AB264870)

Allele-2 : Insertion of the selection cassette in exon 2.

Sanger Sequencing - Human TNK1 knockout HeLa cell line (AB264870)
  • Sanger seq

Unknown

Sanger Sequencing - Human TNK1 knockout HeLa cell line (AB264870)

Allele-1 : 1 bp deletion in exon 2.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 2 and Insertion of the selection cassette in exon 2

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab264870-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255448 Human wild-type HeLa cell line", "number":"AB264870-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab264870 Human TNK1 knockout HeLa cell line", "number":"AB264870-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab264870-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255448 Human wild-type HeLa cell line", "number":"AB264870-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab264870 Human TNK1 knockout HeLa cell line", "number":"AB264870-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab264870-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab264870 Human TNK1 knockout HeLa cell line", "number":"AB264870-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab264870-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab264870 Human TNK1 knockout HeLa cell line", "number":"AB264870-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
TNK1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Tnk1 also known as Tyrosine kinase non-receptor 1 or ACK1 is a non-receptor tyrosine kinase with a molecular mass of approximately 72 kDa. This protein plays a role in signal transduction processes by phosphorylating various substrates. Tnk1 finds expression in different tissues with higher levels observed in the brain heart and testes. Its expression is vital for cellular communication and signaling cascades affecting a variety of cellular functions.
Biological function summary

Tnk1 is involved in regulatory mechanisms that control cell growth and apoptosis. Tnk1 is not part of a well-defined complex but it interacts with various cellular proteins affected by phosphorylation. It has a role in regulating signal pathways that influence gene expression contributing to cellular responses to external stimuli. The ability of Tnk1 to modulate these processes highlights its importance in maintaining cellular homeostasis.

Pathways

Tnk1 integrates into signaling networks such as the epidermal growth factor receptor (EGFR) pathway and Ras signaling pathway. In these pathways Tnk1 interacts with proteins like Epidermal Growth Factor Receptor (EGFR) and Ras assisting in the transduction of extracellular signals that govern cell proliferation and survival. The activity of Tnk1 within these pathways ensures that cells respond appropriately to environmental cues coordinating complex cellular responses.

Tnk1 has been implicated in various cancers including lung and breast cancer. Abnormal expression or mutations in Tnk1 may lead to deregulated cell proliferation contributing to oncogenesis. Associations with other proteins like EGFR further define its role in cancer progression. Understanding the involvement of Tnk1 in these illnesses can provide insights into potential therapeutic approaches highlighting its relevance in disease mechanisms and treatment strategies.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com